Dietary Omega Polyunsaturated Fatty Acid Intake and Patient-Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program

被引:28
作者
Charoenwoodhipong, Prae [1 ]
Harlow, Sioban D. [1 ]
Marder, Wendy [1 ]
Hassett, Afton L. [1 ]
McCune, W. Joseph [1 ]
Gordon, Caroline [2 ]
Helmick, Charles G. [3 ]
Barbour, Kamil E. [3 ]
Wang, Lu [1 ]
Mancuso, Peter [1 ]
Somers, Emily C. [1 ]
Zick, Suzanna M. [1 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
DISEASE-ACTIVITY; SLEEP; SUPPLEMENTATION; FIBROMYALGIA; VALIDATION; PROTECTINS; RESOLVINS; CRITERIA; QUALITY; TRIAL;
D O I
10.1002/acr.23925
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine associations between dietary intake of omega-3 (n-3; generally antiinflammatory) and omega-6 (n-6; generally proinflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE). Methods This study was based on the population-based Michigan Lupus Epidemiology and Surveillance cohort. Estimates of n-3 and n-6 intake were derived from Diet History Questionnaire II items (past year with portion size version). Patient-reported outcomes included self-reported lupus activity (Systemic Lupus Activity Questionnaire [SLAQ]). Multivariable regression, adjusted for age, sex, race, and body mass index, was used to assess associations between absolute intake of n-3 and n-6, as well as the n-6:n-3 ratio, and patient-reported outcomes. Results Among 456 SLE cases, 425 (93.2%) were female, 207 (45.4%) were African American, and the mean +/- SD age was 52.9 +/- 12.3 years. Controlling for potential confounders, the average SLAQ score was significantly higher by 0.3 points (95% confidence interval [95% CI] 0.1, 0.6;P= 0.013) with each unit increase of the n-6:n-3 ratio. Both lupus activity and Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scores were lower with each 1-gram/1,000 kcal increase of n-3 fatty acids (SLAQ regression coefficient beta = -0.8 [95% CI -1.6, 0.0];P= 0.055; PROMIS sleep beta = -1.1 [95% CI -2.0, -0.2];P= 0.017). Higher n-3 intakes were nonsignificantly associated with lower levels of depressive symptoms and comorbid fibromyalgia, and with higher quality of life, whereas results for the n6:n3 ratio trended in the opposite direction. Conclusion This population-based study suggests that higher dietary intake of n-3 fatty acids and lower n-6:n-3 ratios are favorably associated with patient-reported outcomes in SLE, particularly self-reported lupus activity and sleep quality.
引用
收藏
页码:874 / 881
页数:8
相关论文
共 50 条
  • [41] Patient-reported flare frequency is associated with diminished quality of life and family role functioning in systemic lupus erythematosus
    Patricia Katz
    George J. Wan
    Paola Daly
    Lauren Topf
    Erin Connolly-Strong
    Ryan Bostic
    Michael L. Reed
    Quality of Life Research, 2020, 29 : 3251 - 3261
  • [42] The Minimally Important Difference for Patient Reported Outcomes in Systemic Lupus Erythematosus Including the HAQ-DI, Pain, Fatigue, and SF-36
    Colangelo, Kim J.
    Pope, Janet E.
    Peschken, Christine
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (10) : 2231 - 2237
  • [43] Performance of the Patient-Reported Outcomes Measurement Information System 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus
    Katz, Patricia
    Pedro, Sofia
    Michaud, Kaleb
    ARTHRITIS CARE & RESEARCH, 2017, 69 (09) : 1312 - 1321
  • [44] The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus
    Morel, Thomas
    Cano, Stefan
    Bartlett, Susan J.
    Gordon, Caroline
    Haier, Birgit
    Regnault, Antoine
    Schneider, Matthias
    Stach, Christian
    Cleanthous, Sophie
    RHEUMATOLOGY, 2022, 61 (08) : 3329 - 3340
  • [45] Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada
    Bourre-Tessier, Josiane
    Clarke, Ann E.
    Mikolaitis-Preuss, Rachel A.
    Kosinski, Mark
    Bernatsky, Sasha
    Block, Joel A.
    Jolly, Meenakshi
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1327 - 1333
  • [46] Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study
    Uhrenholt, Line
    Hostgaard, Simone
    Pedersen, Julie F.
    Christensen, Robin
    Dreyer, Lene
    Leffers, Henrik C. B.
    Taylor, Peter C.
    Strand, Vibeke
    Jacobsen, Soren
    Voss, Anne
    Gregersen, Jon W.
    Kristensen, Salome
    LUPUS, 2021, 30 (13) : 2124 - 2134
  • [47] Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient-Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus
    Katz, Patricia
    Pedro, Sofia
    Alemao, Evo
    Yazdany, Jinoos
    Dall'Era, Maria
    Trupin, Laura
    Rush, Stephanie
    Michaud, Kaleb
    ACR OPEN RHEUMATOLOGY, 2020, 2 (01) : 53 - 60
  • [48] Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus
    Heijke, Rebecca
    Bjork, Mathilda
    Frodlund, Martina
    McDonald, Laura
    Alemao, Evo
    Sjowall, Christopher
    LUPUS, 2020, 29 (06) : 625 - 630
  • [49] Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance
    Holloway, Laura
    Humphrey, Louise
    Heron, Louise
    Pilling, Claire
    Kitchen, Helen
    Hojbjerre, Lise
    Strandberg-Larsen, Martin
    Hansen, Brian Bekker
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [50] Construct validity of Patient-Reported Outcomes Measurement Information System Paediatric measures in juvenile idiopathic arthritis and systemic lupus erythematosus: cross-sectional evaluation
    Weitzman, Elissa R.
    Gaultney, Amy
    von Scheven, Emily
    Ringold, Sarah
    Mann, Courtney M.
    Magane, Kara M.
    Lin, Li
    Leverty, Renee
    Dennos, Anne
    Hernandez, Alexy
    Lippmann, Steven J.
    Dedeoglu, Fatma
    Marin, Alexandra C.
    Cox, Rachele
    Reeve, Bryce B.
    Schanberg, Laura E.
    BMJ OPEN, 2023, 13 (01):